Aclaris Therapeutics's total assets for Q4 2024 were $220.33M, an increase of 20.80% from the previous quarter. ACRS total liabilities were $64.77M for the fiscal quarter, a 23.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.